SunWay Biotech Co., LTD. Statistics

Total Valuation

TPEX:1271 has a market cap or net worth of TWD 3.48 billion. The enterprise value is 3.43 billion.

Market Cap	3.48B
Enterprise Value	3.43B

Important Dates

The last earnings date was Sunday, April 20, 2025.

Earnings Date	Apr 20, 2025
Ex-Dividend Date	Apr 11, 2024

Share Statistics

TPEX:1271 has 60.39 million shares outstanding. The number of shares has increased by 97.22% in one year.

Current Share Class	60.39M
Shares Outstanding	60.39M
Shares Change (YoY)	+97.22%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	7.07%
Owned by Institutions (%)	n/a
Float	28.66M

Valuation Ratios

The trailing PE ratio is 29.39.

PE Ratio	29.39
Forward PE	n/a
PS Ratio	3.59
PB Ratio	1.07
P/TBV Ratio	4.12
P/FCF Ratio	85.41
P/OCF Ratio	22.17
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.36, with an EV/FCF ratio of 84.25.

EV / Earnings	28.94
EV / Sales	3.54
EV / EBITDA	15.36
EV / EBIT	24.35
EV / FCF	84.25

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.07.

Current Ratio	3.69
Quick Ratio	2.65
Debt / Equity	0.07
Debt / EBITDA	1.09
Debt / FCF	5.99
Interest Coverage	25.43

Financial Efficiency

Return on equity (ROE) is 3.67% and return on invested capital (ROIC) is 2.52%.

Return on Equity (ROE)	3.67%
Return on Assets (ROA)	2.34%
Return on Invested Capital (ROIC)	2.52%
Return on Capital Employed (ROCE)	3.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	2.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.98% in the last 52 weeks. The beta is -0.16, so TPEX:1271's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	-48.98%
50-Day Moving Average	64.98
200-Day Moving Average	79.76
Relative Strength Index (RSI)	42.42
Average Volume (20 Days)	57,206

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:1271 had revenue of TWD 970.18 million and earned 118.57 million in profits. Earnings per share was 1.96.

Revenue	970.18M
Gross Profit	545.04M
Operating Income	140.98M
Pretax Income	142.09M
Net Income	118.57M
EBITDA	188.21M
EBIT	140.98M
Earnings Per Share (EPS)	1.96

Full Income Statement

Balance Sheet

The company has 293.71 million in cash and 243.99 million in debt, giving a net cash position of 49.71 million or 0.82 per share.

Cash & Cash Equivalents	293.71M
Total Debt	243.99M
Net Cash	49.71M
Net Cash Per Share	0.82
Equity (Book Value)	3.27B
Book Value Per Share	54.03
Working Capital	602.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 156.92 million and capital expenditures -116.19 million, giving a free cash flow of 40.73 million.

Operating Cash Flow	156.92M
Capital Expenditures	-116.19M
Free Cash Flow	40.73M
FCF Per Share	0.67

Full Cash Flow Statement

Margins

Gross margin is 56.18%, with operating and profit margins of 14.53% and 12.22%.

Gross Margin	56.18%
Operating Margin	14.53%
Pretax Margin	14.65%
Profit Margin	12.22%
EBITDA Margin	19.40%
EBIT Margin	14.53%
FCF Margin	4.20%

Dividends & Yields

This stock pays an annual dividend of 1.33, which amounts to a dividend yield of 2.33%.

Dividend Per Share	1.33
Dividend Yield	2.33%
Dividend Growth (YoY)	-68.76%
Years of Dividend Growth	n/a
Payout Ratio	50.09%
Buyback Yield	-97.22%
Shareholder Yield	-94.89%
Earnings Yield	3.41%
FCF Yield	1.17%

Dividend Details

Stock Splits

The last stock split was on December 9, 2024. It was a forward split with a ratio of 1.0168388514.

Last Split Date	Dec 9, 2024
Split Type	Forward
Split Ratio	1.0168388514

Scores

TPEX:1271 has an Altman Z-Score of 6.74.

Altman Z-Score	6.74
Piotroski F-Score	n/a